MedAvail, Inc. Set to Trade on NASDAQ Under Ticker Symbol “MDVL”

Written By Lewis & Clark

Our portfolio company MedAvail listed on the NASDAQ (MDVL) as part of a reverse merger. The company is a technology-enabled pharmacy organization, providing turnkey in-clinic pharmacy services through its proprietary robotic dispensing platform, the MedAvail MedCenter, and home delivery operations, to Medicare clinics. MedAvail helps patients to optimize drug adherence, resulting in better health outcomes. Currently deployed in Arizona, California, and Michigan, the company plans to open new care settings in Florida, Illinois and Texas in the future.

Lewis & Clark

Lewis & Clark Ventures was founded by former operators with the conviction that innovation and entrepreneurial talent are plentiful outside of traditional capital centers. We partner with high potential Late Seed and Series A stage B2B software companies. Our vision for success is to become a trusted partner to every entrepreneur that we back and assist in their journey towards scale and significance.

Previous

Summersalt Founders Appear On Today Show

Next

Lewis & Clark Ventures raises $50m for new tech fund